Dr. Susan F Schwartz, M. D. Internal Medicine - Geriatric Medicine Medicare: Not Enrolled in Medicare Practice Location: 561 N Pike Rd, Sarver, PA 16055 Phone: 724-360-0274 Fax: 724-360-0200 |
News Archive
Twenty two years after his sperm was frozen because he had leukaemia, a man has fathered a healthy baby girl.
Clarient, Inc., a premier anatomic pathology and molecular testing services resource for pathologists, oncologists and the biopharmaceutical industry, today reported financial results for the first quarter ended March 31, 2010.
Researchers at the Burrell College of Osteopathic Medicine have found that cancer patients in New Mexico have lower chances of survival when compared to the rest of the nation.
Acucela, a clinical-stage biotechnology company focused on developing new treatments for blinding eye diseases, announced today that a scientific paper co-authored by Ryo Kubota, M.D., Ph.D., chairman, president and chief executive officer of Acucela, has been published in Experimental Eye Research. The paper, "Visual Cycle Modulation in Neurovascular Retinopathy" was also co-authored by scientists from Children's Hospital and Harvard Medical School in Boston and demonstrates for the first time the impact of treatment with a visual cycle modulator (VCM) on retinopathy in an immature eye.
Galapagos NV announced today that it has started a Phase II clinical study for the Company's flagship program GLPG0259, a novel drug being developed for rheumatoid arthritis. In this clinical trial, the safety and efficacy of this novel candidate drug will be tested in RA patients. Galapagos plans to announce interim results by the middle of next year and complete the trial by the end of 2011.
› Verified 2 days ago